SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001590750-20-000104
Filing Date
2020-11-10
Accepted
2020-11-10 16:18:47
Documents
17
Period of Report
2020-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgen-20201110.htm   iXBRL 8-K 39602
2 EX-99.1 mgen-q32020ex991.htm EX-99.1 77976
8 image11a.jpg GRAPHIC 5076
9 mgen-20201110_g1.jpg GRAPHIC 5076
  Complete submission text file 0001590750-20-000104.txt   291411

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgen-20201110.xsd EX-101.SCH 2444
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgen-20201110_cal.xml EX-101.CAL 724
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgen-20201110_def.xml EX-101.DEF 1657
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgen-20201110_lab.xml EX-101.LAB 23970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgen-20201110_pre.xml EX-101.PRE 12660
10 EXTRACTED XBRL INSTANCE DOCUMENT mgen-20201110_htm.xml XML 10993
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36483 | Film No.: 201301359
SIC: 8071 Services-Medical Laboratories